Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Telmisartan/Amlodipine and Rosuvastatin
NCT02933658Phase 1Completed
- Sponsor
- Daewon Pharm
- Start
- Nov 2015
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label trial of telmisartan, amlodipine and rosuvastatin in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Daewon Pharm. Primary endpoints: Area Under the Curve of Reference 1, Maximum Plasma Concentration of Reference 1 and 2 more. Started Nov 2015; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT02933658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933658.